PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs
Neuroblastoma (NB) is the most common and aggressive pediatric cancer, characterized by a remarkable phenotypic diversity and high malignancy. The heterogeneous clinical behavior, ranging from spontaneous remission to fatal metastatic disease, is attributable to NB biology and genetics. Despite majo...
Saved in:
Main Authors: | Serena Vella, Pier Giulio Conaldi, Tullio Florio, Aldo Pagano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2016/3038164 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture Systems
by: Vitale Miceli, et al.
Published: (2019-01-01) -
The Role of PPAR Gamma in Systemic Sclerosis
by: Andréa Tavares Dantas, et al.
Published: (2015-01-01) -
Intracranial Metastatic Neuroblastoma Treated with Gamma Knife Stereotactic Radiosurgery: Report of Two Novel Cases
by: Nathan C. Rowland, et al.
Published: (2012-01-01) -
PPAR Gamma Activity and Control of Bone Mass in Skeletal Unloading
by: P. J. Marie, et al.
Published: (2006-01-01) -
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
by: Anna R. Carta, et al.
Published: (2011-01-01)